Clinical pharmacology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS9
Academic Journal
Presents an abstract of the research manuscript `Verapamil metabolites--Potential P-glycoprotein-mediated multidrug resistance reversal agents,' by C. Woodland, I. Wainer et al from the McGill University.


Related Articles

  • P-Glycoprotein, but not Multidrug Resistance Protein 4, Plays a Role in the Systemic Clearance of Irinotecan and SN-38 in Mice. Tagen, Michael; Yanli Zhuang; Fan Zhang; Harstead, K. Elaine; Jun Shen; Schaiquevich, Paula; Fraga, Charles H.; Panetta, John C.; Waters, Christopher M.; Stewart, Clinton F. // Drug Metabolism Letters;Dec2010, Vol. 4 Issue 4, p195 

    The ATP-binding cassette transporters P-glycoprotein (ABCB1, MDR1) and multidrug resistance protein 4 (MRP4) efflux irinotecan and its active metabolite SN-38 in vitro, and thus may contribute to system clearance of these compounds. Mdr1a/b-/-, Mrp4-/-, and wild-type mice were administered 20 or...

  • HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo. Hu, Zheyi; Zhou, Zaigang; Hu, Yahui; Wu, Jinhui; Li, Yunman; Huang, Wenlong // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Background: Multidrug efflux transporter P-glycoprotein (P-gp) is highly expressed on membrane of tumor cells and is implicated in resistance to tumor chemotherapy. HZ08 is synthesized and studied in order to find a novel P-gp inhibitor. Methods: MDCK-MDR1 monolayer transport, calcein-AM P-gp...

  • As Easy as ABC: Scientists Fish Out Another Drug Resistance Gene. Kuska, Bob // JNCI: Journal of the National Cancer Institute;03/03/99, Vol. 91 Issue 5, p402 

    Reports that scientists have identified several P-glycoprotein genes involved in chemoresistance. Background information on the ABC transporter genes; Explanations from the scientists; Lessons learned by the scientists.

  • Metabolism of (R)-[11C]verapamil in epilepsy patients. Abrahim, Aiman; Luurtsema, Gert; Bauer, Martin; Karch, Rudolf; Baumgartner, Christoph; Kletter, Kurt; Müller, Markus; Langer, Oliver // BMC Pharmacology;2007 Supplement 2, Vol. 7, Special section p1 

    Introduction (R)-[11C]Verapamil (VPM) is a new positron emission tomography (PET) tracer to measure P-glycoprotein (Pgp)-mediated transport at the blood-brain barrier (BBB). Owing to the lack of a suitable reference region in brain that is devoid of P-gp, a metabolite-corrected arterial input...

  • PI-35. Wang, J. S.; Zhu, H. J.; Gibson, B. B.; Donovan, J. L.; Markowitz, J. S.; DeVane, L. C. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP16 

    Background: The ABCB1 drug transporter P-glycoprotein (P-gp) plays an important function in the blood-brain barrier limiting a broad spectrum of substrates from entering the central nervous system. In the present study, the transport activity of P-gp for sertraline, bupropion, and their major...

  • P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. Schneider, Jose; Rubio, Mari-Paz // JNCI: Journal of the National Cancer Institute;6/1/94, Vol. 86 Issue 11, p850 

    Focuses on the role of P-glycoprotein in multidrug resistance to chemotherapy in gynecologic cancer. Overexpression of P-glycoprotein and worsening of prognosis; Mammary carcinomas; Endometrial and cervical carcinomas.

  • Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. van der Kolk, D M; de Vries, E G E; Noordhoek, L; van den Berg, E; van der Pol, M A; Müller, M; Vellenga, E; de Vries, E G // Leukemia (08876924);Oct2001, Vol. 15 Issue 10, p1544 

    The multidrug resistance proteins (MRPs) MRP1, MRP2, MRP3, MRP5 and P-glycoprotein (P-gp) act in concert with each other to give a net resultant pump function in acute myeloid leukemia (AML). The aim of the present study was to analyze the activity of these proteins, which might be upregulated...

  • Preface. Kozikowski, Alan P.; Baraldi, Pier G. // Current Pharmaceutical Design;Feb2000, Vol. 6 Issue 3, p1l 

    Introduces articles about treatments and cures for cancer published in the February 2000 issue of the periodical 'Current Pharmaceutical Design.' Role of p-glycoprotein in chemotherapeutic drug resistance; Importance of oxidative stress and electron transfer in the mechanism of action of...

  • What is the Precise Role of Human MDR 1 Protein in Chemotherapeutic Drug Resistance. Roepe, Paul D. // Current Pharmaceutical Design;Feb2000, Vol. 6 Issue 3, p241 

    Elucidating the molecular function of hu MDR 1 protein (also called P-glycoprotein or P-gp 1 ) and the precise role this protein plays in clinically relevant tumor drug resistance remains a perplexing problem. Hundreds of reports over the past decades summarize a dizzying array of observations...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics